S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.03%) $0.927
USD/NOK
(0.21%) $10.86
USD/GBP
(0.07%) $0.793
USD/RUB
(-0.34%) $92.26

Realtime updates for Lipigon Pharmaceuticals [LPGO.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 07:53

-4.24% SEK 0.361

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 07:53):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease and familial chylomicronemia syndrome; a gene therapy project for the lipodystrophy, a rare disease of altered fat distribution in the body; therapeutics for dyslipidemia, a general lipid disorder; and RNA drug project for acute respiratory distress syndrome...

Stats
Today's Volume 238 548
Average Volume 692 047
Market Cap 45.64M
EPS SEK0 ( 2024-02-22 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E 9.03
ATR14 SEK0.00400 (1.11%)

Lipigon Pharmaceuticals Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lipigon Pharmaceuticals Financials

Annual 2023
Revenue: SEK16.41M
Gross Profit: SEK-12.58M (-76.66 %)
EPS: SEK-0.190
Q4 2023
Revenue: SEK0
Gross Profit: SEK-6 000.00 (0.00 %)
EPS: SEK-0.0882
Q3 2023
Revenue: SEK357 000
Gross Profit: SEK-5.40M (-1 513.45 %)
EPS: SEK-0.0295
Q2 2023
Revenue: SEK16.05M
Gross Profit: SEK7.09M (44.15 %)
EPS: SEK0.110

Financial Reports:

No articles found.

Lipigon Pharmaceuticals

Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease and familial chylomicronemia syndrome; a gene therapy project for the lipodystrophy, a rare disease of altered fat distribution in the body; therapeutics for dyslipidemia, a general lipid disorder; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia, cardiovascular disease, and other metabolic diseases. The company was founded in 2010 and is based in Umeå, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators